A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Calibr, a division of Scripps Research
Hackensack Meridian Health
University of Chicago
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
BeOne Medicines
Eli Lilly and Company
Acerta Pharma BV
University Hospital, Lille
BeOne Medicines
Boryung Pharmaceutical Co., Ltd
Ascentage Pharma Group Inc.
University of Maryland, Baltimore
Janssen Research & Development, LLC
Janssen Pharmaceutical K.K.
Xencor, Inc.
University College, London
BeiGene
BeiGene
X4 Pharmaceuticals
Calibr, a division of Scripps Research
University of Ulm
City of Hope Medical Center
University of Rochester
City of Hope Medical Center
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Mayo Clinic
University of Nebraska
Stanford University
Dartmouth-Hitchcock Medical Center
Agenus Inc.
French Innovative Leukemia Organisation
Canadian Cancer Trials Group
Canadian Cancer Trials Group
TG Therapeutics, Inc.
Eastern Cooperative Oncology Group
Abramson Cancer Center at Penn Medicine
Brown University
Karyopharm Therapeutics Inc
Dana-Farber Cancer Institute
Scripps Health
Columbia University
Dana-Farber Cancer Institute
TG Therapeutics, Inc.
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Dana-Farber Cancer Institute